POMC and perinatal asphyxia: Conventionally, resistance to treatment varies depending on the pathogenesis of WS, and recent reports have shown that patients with WS caused by structural acquired diseases (such as neonatal stroke and hypoxic-ischemic encephalopathy) are more responsive to ACTH treatment than patients with congenital disease [33].